The Effects of Using the Web-Based Double Eye Control Program on Medication Error

April 15, 2024 updated by: Beste Ozguven Oztornaci, Izmir Katip Celebi University

The Effects of Using the Web-Based Double Eye Control Program on Medication of High Risk Drugs in Pediatric Patients: The Effect of Web-Based Double Eye Control Program

Methods: The study was carried out as a quasi-experimental study in the Pediatric Surgery Clinics of a university hospital using the "Pre-Test-Post-Test Model in a Single Group". The sample of the study consisted of all high-risk drugs administered by 24 nurses working in these clinics, taking part in medication and agreeing to take part in the study. Data were collected by the researcher using the Medication Observation Form. The Form was created based on the literature, and by making use of the "10 Correct Rules in Medication" and the Medication Skills Steps in the Double Eye Control Program. In the first step, medication error rates were determined through observation method. In the second step; the Web-Based Double-Eye Control Program, which is a standard drug dose calculation and medication program created by the researchers, was started to be implemented. Medication error rates were determined again through post-intervention observation method. Informed voluntary consent, ethics committee and hospital permissions were obtained for the implementation of the study.

Study Overview

Status

Completed

Detailed Description

Background: In this study, it was aimed to examine the effect of using Web Based Double-Eye Control Program as a new decision support system in preventing errors and standardization in high-risk medications of pediatric nurses.

Methods: The study was carried out as a quasi-experimental study in the Pediatric Surgery Clinics of a university hospital using the "Pre-Test-Post-Test Model in a Single Group". The sample of the study consisted of all high-risk drugs (532 before the intervention, 538 after the intervention, a total of 1070 drug doses) administered by 24 nurses working in these clinics, taking part in medication and agreeing to take part in the study. Data were collected by the researcher using the Medication Observation Form. The Form was created based on the literature, and by making use of the "10 Correct Rules in Medication" and the Medication Skills Steps in the Double Eye Control Program. In the first step, medication error rates were determined through observation method. In the second step; the Web-Based Double-Eye Control Program, which is a standard drug dose calculation and medication program created by the researchers, was started to be implemented. Medication error rates were determined again through post-intervention observation method. Informed voluntary consent, ethics committee and hospital permissions were obtained for the implementation of the study.

Study Type

Observational

Enrollment (Actual)

1070

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Çi̇ğli̇
      • İzmir, Çi̇ğli̇, Turkey, 35620
        • İzmir Katip Çelebi University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

The population of the research was composed of Nurses working in the Pediatric Surgery Department Clinic (Pediatric Surgery, Pediatric Surgery Intensive Care, Neonatal Surgery Intensive Care Clinics) of a university hospital in Turkey between November 2017 and June 2018, and all high-risk drugs they administered.

Description

Inclusion Criteria:

  • The medications observed were to be in the high-risk drug group for children,
  • Volunteering of nurses working in the clinic to participate in the research,
  • Nurses working in the clinic should have had proper level of internet usage knowledge to use a web-based program.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Medication errors during the application of high-risk drugs
Medication Errors During the Application of High-risk Drugs Before and After Using Web-Based Double-Eye Control Program
Web-Based Double-Eye Control Program, a web-based drug dose calculation program, is compatible with smartphones, tablets and computers. On the interface of the website, the nurse is required to enter data such as the age, weight, medications and doses ordered by the physician of the patient. When all these data are entered, the amount of medication that the nurse should give and whether the ordered dose is within the safe dose range for the patient are calculated by the program, so that the nurse can control her own calculations. On the other interface of the website, there are medication instructions uploaded by the researchers. With this interface, nurses access all pharmacological information about especially high-risk drugs (indications, contraindications, interacting drugs and fluids, fluids to be used for diluting, medication route, medication pace, etc.) and information that will enable the medication to be carried out in a standard way.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Error rates
Time Frame: Between January 2017 and September 2018
Medication errors during administration of high-risk drugs in pediatric patients
Between January 2017 and September 2018

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2017

Primary Completion (Actual)

June 30, 2018

Study Completion (Actual)

September 30, 2018

Study Registration Dates

First Submitted

December 30, 2023

First Submitted That Met QC Criteria

April 15, 2024

First Posted (Actual)

April 17, 2024

Study Record Updates

Last Update Posted (Actual)

April 17, 2024

Last Update Submitted That Met QC Criteria

April 15, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Main Heading (Descriptor) Terms

Clinical Trials on Web-Based Double-Eye Control Program

Subscribe